New Jersey recalls

Ophthalmic procedure packs may have incomplete seals affecting sterility.

A certain component of affected devices was not delivered within specification and contained impurities.

A certain component of affected devices was not delivered within specification and contained impurities.

It is possible to exceed the maximum allowed Air Kerma rate (AKR) of 88mGy/min for pulsed fluoro exams. This can happen in case the framerate is increased on the NX workstation when ABS is not enabled.

Undeclared pecan

Undeclared wheat

Product may be contaminated with Listeria monocytogenes.

Undeclared allergens (Peanut) due to mispackaging

Presence of particulate matter: potential presence of metal particulates in the product.

Presence of particulate matter: potential presence of metal particulates in the product.

Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.

Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.

Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.

When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia.

Removal of affected lot of screws due to labeling error.

Due to firm mistakenly distributing product within the U.S. without FDA premarket clearance/approval.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

IFU and device kit labeling contains misleading statements leading to improper securing of the device resulting in the potential to fall out during use.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Due to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

Treatment reagent functionality in respiratory specimens fluidification cannot be guaranteed.

Treatment reagent functionality in respiratory specimens liquification cannot be guaranteed.